Cancers

Distinct Gene Expression Profiles of Matched Primary and Metastatic Triple-Negative Breast Cancers.  14. 2022

Regulation of NKG2D Stress Ligands and Its Relevance in Cancer Progression.  14. 2022

Pre-Clinical Study Evaluating Novel Protein Phosphatase 2A Activators as Therapeutics for Neuroblastoma.  14. 2022

Modulation of the Tumor Microenvironment with Trastuzumab Enables Radiosensitization in HER2+ Breast Cancer.  14. 2022

Repair-Assisted Damage Detection Reveals Biological Disparities in Prostate Cancer between African Americans and European Americans.  14. 2022

Targeting High-Risk Neuroblastoma Patient-Derived Xenografts with Oncolytic Virotherapy.  14. 2022

Test/Retest Reliability and Validity of Remote vs. In-Person Anthropometric and Physical Performance Assessments in Cancer Survivors and Supportive Partners.  14. 2022

Hpve6-usp46 mediated cdt2 stabilization reduces set8 mediated h4k20-methylation to induce gene expression changes.  14. 2022

Higher radiation dose to the immune cells correlates with worse tumor control and overall survival in patients with stage iii nsclc: A secondary analysis of rtog0617.  13. 2021

The brd9/7 inhibitor tp-472 blocks melanoma tumor growth by suppressing ecm-mediated oncogenic signaling and inducing apoptosis.  13. 2021

Toll-like receptor-4 antagonist enhances the repair of ultraviolet radiation-induced DNA damage and augments anti-tumor immune responses in mice.  13. 2021

Genomic landscape of angiosarcoma: A targeted and immunotherapy biomarker analysis.  13. 2021

The effect of a histone deacetylase inhibitor (AR-42) and zoledronic acid on adult T-cell leukemia/lymphoma osteolytic bone tumors.  13. 2021

Genomic characterization and therapeutic targeting of hpv undetected cervical carcinomas.  13. 2021

Targeted liposomal chemotherapies to treat triple-negative breast cancer.  13. 2021

Merkel cell carcinoma of the head and neck: Epidemiology, pathogenesis, current state of treatment and future directions.  13. 2021

The bet inhibitor JQ1 augments the antitumor efficacy of gemcitabine in preclinical models of pancreatic cancer.  13. 2021

Knocking out the vitamin d receptor enhances malignancy and decreases responsiveness to vitamin d3 hydroxyderivatives in human melanoma cells.  13. 2021

Serine-threonine kinase receptor-associated protein (Strap) knockout decreases the malignant phenotype in neuroblastoma cell lines.  13. 2021

Cathepsin k: A novel diagnostic and predictive biomarker for renal tumors.  13. 2021

Diet-induced obesity impairs outcomes and induces multi-factorial deficiencies in effector t cell responses following anti-ctla-4 combinatorial immunotherapy in renal tumor-bearing mice.  13. 2021

Positron emission tomography imaging of macrophages in cancer.  13. 2021

Artificial tumor microenvironments in neuroblastoma.  13. 2021

Assessing preclinical research models for immunotherapy for gynecologic malignancies.  13. 2021

Identification of BXDC2 as a key downstream effector of the androgen receptor in modulating cisplatin sensitivity in bladder cancer.  13:1-13. 2021

Integrin αvβ3 engagement regulates glucose metabolism and migration through focal adhesion kinase (Fak) and protein arginine methyltransferase 5 (prmt5) in glioblastoma cells.  13:1-16. 2021

The effects of single nucleotide polymorphisms in cancer rnai therapies.  12:1-20. 2020

Elavl1 role in cell fusion and tunneling membrane nanotube formations with implication to treat glioma heterogeneity.  12:1-18. 2020

The antidiabetic agent acarbose improves anti-PD-1 and rapamycin efficacy in preclinical renal cancer.  12:1-19. 2020

Actively targeted nanodelivery of echinomycin induces autophagy-mediated death in chemoresistant pancreatic cancer in vivo.  12:1-17. 2020

MiR-216b/Smad3/BCL-2 axis is involved in smoking-mediated drug resistance in non-small cell lung cancer.  12:1-16. 2020

Association of allostatic load with all-cause and cancer mortality by race and body mass index in the regards cohort.  12:1-15. 2020

Identification of distinct heterogenic subtypes and molecular signatures associated with african ancestry in triple negative breast cancer using quantified genetic ancestry models in admixed race populations.  12. 2020

Patient-derived xenograft models of pancreatic cancer: Overview and comparison with other types of models.  12. 2020

Biological and clinical significance of the CCR5/CCL5 axis in hepatocellular carcinoma.  12. 2020

PAICS, a purine nucleotide metabolic enzyme, is involved in tumor growth and the metastasis of colorectal cancer.  12. 2020

Utilizing genome-wide mrna profiling to identify the cytotoxic chemotherapeutic mechanism of triazoloacridone C-1305 as direct microtubule stabilization.  12. 2020

Inhibiting WNT ligand production for improved immune recognition in the Ovarian tumor microenvironment.  12. 2020

An update on neurofibromatosis type 1-associated gliomas.  12. 2020

Cachexia and sarcopenia in older adults with cancer: A comprehensive review.  11. 2019

Immunotherapy in pediatric solid tumors—a systematic review.  11. 2019

Immunohistochemical and Molecular Features of Melanomas Exhibiting Intratumor and Intertumor Histomorphologic Heterogeneity..  11. 2019

Prognostic role of androgen receptor in triple negative breast cancer: A multi-institutional study.  11. 2019

A review of the role of wnt in cancer immunomodulation.  11. 2019

Pulmonary carcinoid surface receptor modulation using histone deacetylase inhibitors.  11. 2019

Genomic profiling of the steroidogenic acute regulatory protein in breast cancer: In silico assessments and a mechanistic perspective.  11. 2019

Review: Targeting the transforming growth factor-beta pathway in ovarian cancer.  11. 2019

Effects of SAHA and EGCG on growth potentiation of triple-negative breast cancer cells.  11. 2019

Contemporary management of localized resectable pancreatic cancer.  10. 2018

Regulation of EMT in colorectal cancer: A culprit in metastasis.  9. 2017

The impact of DNA repair pathways in cancer biology and therapy.  9. 2017

Cell proliferation in neuroblastoma.  8. 2016

Cancer stem cells and their interaction with the tumor microenvironment in neuroblastoma.  8:1-13. 2015

Aberrant GLI1 activation in DNA damage response, carcinogenesis and chemoresistance.  7:2330-2352. 2015

The impact of hedgehog signaling pathway on DNA repair mechanisms in human cancer.  7:1333-1348. 2015

PARP-1: Friend or foe of DNA damage and repair in tumorigenesis?.  5:943-958. 2013

Advances in viral vector-based TRAIL gene therapy for cancer.  3:603-620. 2011

Cancer stem cells and pediatric solid tumors.  3:298-318. 2011

Treatment Resistance Mechanisms of Malignant Glioma Tumor Stem Cells.  3:621-635. 2011